Clinical Trial Update: Brain Excitability in Patients With Succinic Semialdehyde Dehydrogenase Deficiency

View source ↗

Summary

This document provides an update on a completed clinical trial investigating brain excitability in patients with succinic semialdehyde dehydrogenase deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Succinic Semialdehyde Dehydrogenase Deficiency

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Succinic Semialdehyde, Dehydrogenase Deficiency | Status: COMPLETED